Raaj Trivedi, BioClinica's VP Commercial Operations, just received 17,500 options from the company. The strike price of the options received was $1.34, and these expire on February 28, 2026. Trivedi now owns at least 17,500 options on the company.
Some additional info was provided as follows:
25% of the shares subject to the option shall vest on the first annual anniversary of the Vesting Commencement Date (2/29/16) with the balance vesting in equal monthly installments thereafter until fully vested on February 29, 2020.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To re ceive a free e-mail notification whenever BioClinica makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept director just picked up 5,667 shares - March 29, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2017
Biocept Just Filed Its Annual Report: 12. Net Loss per Co... - March 28, 2017
Shareholder Director - March 23, 2017
CFO of Biocept was just granted 16,383 options - March 22, 2017